SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment no. 1) Quarterly Report under Section 13 or 15(d) of The Securities Exchange Act of 1934 For quarter ended: March 31, 1995 Commission File No. 0-11178 UTAH MEDICAL PRODUCTS, INC. (Exact name of Registrant as specified in its charter) UTAH 87-0342734 (State or other jurisdiction IRS Employer incorporation or organization) Identification No. 7043 South 300 West Midvale Utah 84047 (Address of principal executive offices) Registrant's telephone number:(801) 566-1200 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes (X) No ( ) The number of shares outstanding of the registrant's common stock as of May 12, 1995: 9,785,135 SIGNATURES Pursuant to the requirements of the Securities Exchanges Act of 1934, the registrant has duly caused this amendment to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. REGISTRANT Date:May 15, 1995 By:/s/Kevin L. Cornwell Kevin L. Cornwell President and CEO Date:May 15, 1995 By:/s/Kevin L. Cornwell Kevin L. Cornwell Secretary and CFO